{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:18:48Z","timestamp":1794745128775,"version":"4.9.1"},"reference-count":197,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7262191"],"award-info":[{"award-number":["7262191"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104847"],"award-info":[{"award-number":["82104847"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374366"],"award-info":[{"award-number":["82374366"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.biopha.2026.119938","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:17:27Z","timestamp":1789964247000},"page":"119938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting immune\u2013hemodynamic coupling in early diabetic kidney disease: Mechanisms, biomarkers, and therapeutic opportunities"],"prefix":"10.1016","volume":"204","author":[{"given":"Lei","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyu","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.biopha.2026.119938_bib1","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"10.1016\/j.biopha.2026.119938_bib2","article-title":"Update on pathogenesis of glomerular hyperfiltration in early diabetic kidney disease","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119938_bib3","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2337\/dc22-2003","article-title":"Glomerular hyperfiltration predicts kidney function decline and mortality in type 1 and type 2 diabetes: a 21-year longitudinal study","volume":"46","author":"Moriconi","year":"2023","journal-title":"Diabetes care"},{"issue":"5","key":"10.1016\/j.biopha.2026.119938_bib4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrneph.2012.19","article-title":"Glomerular hyperfiltration: definitions, mechanisms and clinical implications","volume":"8","author":"Helal","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119938_bib5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00125-009-1268-0","article-title":"Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis","volume":"52","author":"Magee","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2026.119938_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1714170","article-title":"Glomerular hyperfiltration defined by eGFR and long-term clinical outcomes: a systematic review and meta-analysis","volume":"12","author":"Yang","year":"2026","journal-title":"Front. Med."},{"issue":"4","key":"10.1016\/j.biopha.2026.119938_bib7","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1681\/ASN.2016060666","article-title":"Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment","volume":"28","author":"Tonneijck","year":"2017","journal-title":"J. Am. Soc. Nephrol. JASN"},{"issue":"3","key":"10.1016\/j.biopha.2026.119938_bib8","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/s41440-024-02092-w","article-title":"Redefining glomerular hyperfiltration: pathophysiology, clinical implications, and novel perspectives","volume":"48","author":"Kishi","year":"2025","journal-title":"Hypertens. Res. Off. J. Jpn. Soc. Hypertens."},{"issue":"5","key":"10.1016\/j.biopha.2026.119938_bib9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41581-021-00393-8","article-title":"Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors","volume":"17","author":"DeFronzo","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119938_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41581-020-0256-y","article-title":"The tubular hypothesis of nephron filtration and diabetic kidney disease","volume":"16","author":"Vallon","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.biopha.2026.119938_bib11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-physiol-031620-095920","article-title":"Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function","volume":"83","author":"Vallon","year":"2021","journal-title":"Annu. Rev. Physiol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119938_bib12","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s00125-010-1794-9","article-title":"The clinical significance of hyperfiltration in diabetes","volume":"53","author":"Jerums","year":"2010","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.biopha.2026.119938_bib13","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.2337\/dc11-2189","article-title":"Glomerular hyperfiltration and renal disease progression in type 2 diabetes","volume":"35","author":"Ruggenenti","year":"2012","journal-title":"Diabetes care"},{"issue":"4","key":"10.1016\/j.biopha.2026.119938_bib14","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.kint.2017.11.034","article-title":"Advanced glycation end products in the pathogenesis of chronic kidney disease","volume":"93","author":"Rabbani","year":"2018","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.biopha.2026.119938_bib15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1089\/ars.2016.6664","article-title":"Diabetes and Kidney Disease: Role of Oxidative Stress","volume":"25","author":"Jha","year":"2016","journal-title":"Antioxid. & Redox Signal."},{"issue":"4","key":"10.1016\/j.biopha.2026.119938_bib16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1681\/ASN.2018090896","article-title":"Single-cell RNA profiling of glomerular cells shows dynamic changes in experimental diabetic kidney disease","volume":"30","author":"Fu","year":"2019","journal-title":"J. Am. Soc. Nephrol. JASN"},{"issue":"39","key":"10.1016\/j.biopha.2026.119938_bib17","doi-asserted-by":"crossref","first-page":"19619","DOI":"10.1073\/pnas.1908706116","article-title":"The single-cell transcriptomic landscape of early human diabetic nephropathy","volume":"116","author":"Wilson","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2026.119938_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ajpath.2024.07.007","article-title":"Single-cell advances in investigating and understanding chronic kidney disease and diabetic kidney disease","volume":"195","author":"Bhayana","year":"2025","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2026.119938_bib19","article-title":"Immune-mediated renal injury in diabetic kidney disease: from mechanisms to therapy","volume":"16","author":"Ma","year":"2025","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119938_bib20","doi-asserted-by":"crossref","first-page":"F301","DOI":"10.1152\/ajprenal.00266.2023","article-title":"Macrophage polarization and signaling in diabetic kidney disease: a catalyst for disease progression","volume":"326","author":"Youssef","year":"2024","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119938_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2021.107880","article-title":"Relationships between inflammation, hemodynamic function and RAAS in longstanding type 1 diabetes and diabetic kidney disease","volume":"35","author":"Ambinathan","year":"2021","journal-title":"J. Diabetes Complicat."},{"issue":"6","key":"10.1016\/j.biopha.2026.119938_bib22","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.kint.2022.08.026","article-title":"The single-cell landscape of kidney immune cells reveals transcriptional heterogeneity in early diabetic kidney disease","volume":"102","author":"Fu","year":"2022","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2026.119938_bib23","article-title":"Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119938_bib24","article-title":"T cells and their products in diabetic kidney disease","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119938_bib25","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1038\/s41598-019-38811-4","article-title":"Interleukin 17A promotes diabetic kidney injury","volume":"9","author":"Ma","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119938_bib26","article-title":"Mechanistic pathogenesis of endothelial dysfunction in diabetic nephropathy and retinopathy","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119938_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s11658-023-00423-2","article-title":"Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets","volume":"28","author":"Janaszak-Jasiecka","year":"2023","journal-title":"Cell. & Mol. Biol. Lett."},{"key":"10.1016\/j.biopha.2026.119938_bib28","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12933-014-0158-z","article-title":"The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats","volume":"13","author":"Vallejo","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119938_bib29","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/ki.2014.143","article-title":"Endothelin and endothelin antagonists in chronic kidney disease","volume":"86","author":"Kohan","year":"2014","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.biopha.2026.119938_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27021097","article-title":"Inflammation and Diabetic Kidney Disease","volume":"27","author":"Zhang","year":"2026","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119938_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/jcm15030921","article-title":"Residual Renal Risk in Diabetic Nephropathy Despite Contemporary Therapies","volume":"15","author":"Speeckaert","year":"2026","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.biopha.2026.119938_bib32","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.kint.2022.05.012","article-title":"Molecular mechanisms and therapeutic targets for diabetic kidney disease","volume":"102","author":"Tuttle","year":"2022","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.biopha.2026.119938_bib33","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1016\/j.ekir.2024.09.019","article-title":"Unraveling Diabetic Kidney Disease: The Roles of Mitochondrial Dysfunction and Immunometabolism","volume":"9","author":"Narongkiatikhun","year":"2024","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.biopha.2026.119938_bib34","article-title":"New insights into the role of immunity and inflammation in diabetic kidney disease in the omics era","volume":"15","author":"Hu","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119938_bib35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrneph.2010.152","article-title":"Endothelial dysfunction as a potential contributor in diabetic nephropathy","volume":"7","author":"Nakagawa","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119938_bib36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.diabet.2018.04.001","article-title":"Complement activation in patients with diabetic nephropathy","volume":"45","author":"Li","year":"2019","journal-title":"Diabetes & Metab."},{"key":"10.1016\/j.biopha.2026.119938_bib37","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.3389\/fimmu.2020.02073","article-title":"Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes","volume":"11","author":"Duan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119938_bib38","article-title":"Complement Deposition Predicts Worsening Kidney Function and Underlines the Clinical Significance of the 2010 Renal Pathology Society Classification of Diabetic Nephropathy","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119938_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/CIRCRESAHA.121.320239","article-title":"Tubular IL-1\u03b2 Induces Salt Sensitivity in Diabetes by Activating Renal Macrophages","volume":"131","author":"Veiras","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2026.119938_bib40","article-title":"Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications","volume":"7","author":"Donate-Correa","year":"2020","journal-title":"Front. Med."},{"issue":"4","key":"10.1016\/j.biopha.2026.119938_bib41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.humimm.2014.02.007","article-title":"The alteration of Th1\/Th2\/Th17\/Treg paradigm in patients with type 2 diabetes mellitus: Relationship with diabetic nephropathy","volume":"75","author":"Zhang","year":"2014","journal-title":"Human. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119938_bib42","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.19082\/1613","article-title":"Role of alteration in Treg\/Th17 cells' balance in nephropathic patients with Type 2 diabetes mellitus","volume":"7","author":"Abouzeid","year":"2015","journal-title":"Electron. Physician"},{"issue":"5","key":"10.1016\/j.biopha.2026.119938_bib43","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1681\/ASN.0000000966","article-title":"Inhibition of IL-33 in Diabetic Kidney Disease: A Randomized, Placebo-Controlled Phase 2b Trial","volume":"37","author":"Hofherr","year":"2026","journal-title":"J. Am. Soc. Nephrol. JASN"},{"issue":"6","key":"10.1016\/j.biopha.2026.119938_bib44","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.ekir.2024.03.009","article-title":"Inhibition of Interleukin-33 to Reduce Glomerular Endothelial Inflammation in Diabetic Kidney Disease","volume":"9","author":"Hofherr","year":"2024","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.biopha.2026.119938_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.106012","article-title":"Soluble urokinase receptor is a kidney-specific vasoconstrictor","volume":"121","author":"Rasmussen","year":"2025","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.biopha.2026.119938_bib46","doi-asserted-by":"crossref","DOI":"10.1172\/JCI197141","article-title":"The role of suPAR and related proteins in kidney, heart diseases, and diabetes","volume":"136","author":"Reiser","year":"2026","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.biopha.2026.119938_bib47","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1440-1797.2006.00576.x","article-title":"Macrophage accumulation in human progressive diabetic nephropathy","volume":"11","author":"Nguyen","year":"2006","journal-title":"Nephrol. (Carlton Vic. )"},{"key":"10.1016\/j.biopha.2026.119938_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2026.1744430","article-title":"Capturing the inflammatory landscape within kidney compartments of human diabetic kidney disease: a digital spatial profiling study","volume":"17","author":"Elhusseiny","year":"2026","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119938_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114253","article-title":"Protective role for kidney TREM2(high) macrophages in obesity- and diabetes-induced kidney injury","volume":"43","author":"Subramanian","year":"2024","journal-title":"Cell. Rep."},{"issue":"11","key":"10.1016\/j.biopha.2026.119938_bib50","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.21037\/tau-24-569","article-title":"Depletion of intrinsic renal macrophages with moderate-to-high expression of CD163, MRC1, PTH2R, PDE4D, and CUBN in regulating podocyte injury in diabetic nephropathy: a single-cell RNA sequencing analysis","volume":"13","author":"Guo","year":"2024","journal-title":"Transl. Androl. Urol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119938_bib51","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/ki.2013.11","article-title":"The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy","volume":"83","author":"Lin","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2026.119938_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.907504","article-title":"The Role of the NLRP3 Inflammasome in Mediating Glomerular and Tubular Injury in Diabetic Nephropathy","volume":"13","author":"Williams","year":"2022","journal-title":"Front. Physiol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119938_bib53","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/MNH.0000000000000344","article-title":"The kallikrein-kinin system in diabetic kidney disease","volume":"26","author":"Liu","year":"2017","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"2","key":"10.1016\/j.biopha.2026.119938_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229401","article-title":"Aberrant activation of bone marrow Ly6C high monocytes in diabetic mice contributes to impaired glucose tolerance","volume":"15","author":"Ikeda","year":"2020","journal-title":"PloS. One"},{"key":"10.1016\/j.biopha.2026.119938_bib55","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cytogfr.2025.05.007","article-title":"Exploring inflammatory and fibrotic mechanisms driving diabetic nephropathy progression","volume":"84","author":"Ansari","year":"2025","journal-title":"Cytokine & Growth Factor. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2026.119938_bib56","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/HJH.0b013e32833992ef","article-title":"Interleukin-6 inhibits endothelial nitric oxide synthase activation and increases endothelial nitric oxide synthase binding to stabilized caveolin-1 in human vascular endothelial cells","volume":"28","author":"Hung","year":"2010","journal-title":"J. Hypertens."},{"issue":"12","key":"10.1016\/j.biopha.2026.119938_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122563","article-title":"Cellular and Oxidative Mechanisms Associated with Interleukin-6 Signaling in the Vasculature","volume":"18","author":"Didion","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119938_bib58","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/jdi.13725","article-title":"Role of the adaptive immune system in diabetic kidney disease","volume":"13","author":"Kong","year":"2022","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.biopha.2026.119938_bib59","article-title":"Inflammatory mechanisms in diabetic nephropathy: emerging insights and targeted therapeutics","volume":"12","author":"Lin","year":"2025","journal-title":"Front. Med."},{"issue":"9-10","key":"10.1016\/j.biopha.2026.119938_bib60","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.cca.2010.01.036","article-title":"Aberrant cytokines\/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy","volume":"411","author":"Wu","year":"2010","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2026.119938_bib61","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12020-022-03043-6","article-title":"Changes of Th17 cells, regulatory T cells, Treg\/Th17, IL-17 and IL-10 in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"76","author":"Zi","year":"2022","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.biopha.2026.119938_bib62","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00109-011-0816-5","article-title":"The imbalance of Th17\/Th1\/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications","volume":"90","author":"Zeng","year":"2012","journal-title":"J. Mol. Med. (Berl. Ger. )"},{"issue":"1","key":"10.1016\/j.biopha.2026.119938_bib63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41581-018-0074-7","article-title":"Effector and regulatory B cells in immune-mediated kidney disease","volume":"15","author":"Oleinika","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.biopha.2026.119938_bib64","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/639469","article-title":"Fisetin inhibits hyperglycemia-induced proinflammatory cytokine production by epigenetic mechanisms","volume":"2012","author":"Kim","year":"2012","journal-title":"Evid. -Based Complement. Altern. Med. eCAM"},{"key":"10.1016\/j.biopha.2026.119938_bib65","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.molimm.2019.05.014","article-title":"Decreased number of CD19(+)CD24(hi)CD38(hi) regulatory B cells in Diabetic nephropathy","volume":"112","author":"Li","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.biopha.2026.119938_bib66","article-title":"The immune tolerance role of Bregs in inhibiting human inflammatory diseases, with a focus on diabetes mellitus","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119938_bib67","doi-asserted-by":"crossref","first-page":"6657","DOI":"10.2147\/JIR.S391473","article-title":"TNF-\u03b1 and IL-1\u03b2 Promote Renal Podocyte Injury in T2DM Rats by Decreasing Glomerular VEGF\/eNOS Expression Levels and Altering Hemodynamic Parameters","volume":"15","author":"Wang","year":"2022","journal-title":"J. Inflamm. Res."},{"issue":"4","key":"10.1016\/j.biopha.2026.119938_bib68","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.kint.2022.07.015","article-title":"Podocyte as the link between sterile inflammation and diabetic kidney disease","volume":"102","author":"Lass\u00e9n","year":"2022","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.biopha.2026.119938_bib69","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1681\/ASN.2010111210","article-title":"Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy","volume":"23","author":"Lin","year":"2012","journal-title":"J. Am. Soc. Nephrol. JASN"},{"issue":"9","key":"10.1016\/j.biopha.2026.119938_bib70","doi-asserted-by":"crossref","first-page":"F993","DOI":"10.1152\/ajprenal.00637.2014","article-title":"Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy","volume":"308","author":"Kim","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119938_bib71","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cytogfr.2006.09.011","article-title":"The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications","volume":"17","author":"Navarro","year":"2006","journal-title":"Cytokine & Growth Factor. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2026.119938_bib72","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/21655979.2021.2012550","article-title":"Sitagliptin protects renal glomerular endothelial cells against high glucose-induced dysfunction and injury","volume":"13","author":"Xu","year":"2022","journal-title":"Bioengineered"},{"issue":"5","key":"10.1016\/j.biopha.2026.119938_bib73","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1172\/JCI38399","article-title":"Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury","volume":"119","author":"Heymann","year":"2009","journal-title":"J. Clin. Investig."},{"issue":"12","key":"10.1016\/j.biopha.2026.119938_bib74","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1681\/ASN.2009030337","article-title":"Th1 and Th17 cells induce proliferative glomerulonephritis","volume":"20","author":"Summers","year":"2009","journal-title":"J. Am. Soc. Nephrol. JASN"},{"issue":"3","key":"10.1016\/j.biopha.2026.119938_bib75","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1681\/ASN.2014111136","article-title":"Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis","volume":"27","author":"Mohamed","year":"2016","journal-title":"J. Am. Soc. Nephrol. JASN"},{"issue":"6","key":"10.1016\/j.biopha.2026.119938_bib76","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.kint.2018.12.031","article-title":"Interleukin-17A blockade reduces albuminuria and kidney injury in an accelerated model of diabetic nephropathy","volume":"95","author":"Lavoz","year":"2019","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.biopha.2026.119938_bib77","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/CIRCULATIONAHA.113.005081","article-title":"Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus","volume":"129","author":"Cherney","year":"2014","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.biopha.2026.119938_bib78","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3349\/ymj.2002.43.2.183","article-title":"Inducible nitric oxide synthase (iNOS) expression is increased in lipopolysaccharide (LPS)-stimulated diabetic rat glomeruli: effect of ACE inhibitor and angiotensin II receptor blocker","volume":"43","author":"Lee","year":"2002","journal-title":"Yonsei Med. J."},{"issue":"1-2","key":"10.1016\/j.biopha.2026.119938_bib79","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11010-013-1733-4","article-title":"NOX1 abet mesangial fibrogenesis via iNOS induction in diabetes","volume":"382","author":"Gao","year":"2013","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119938_bib80","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1152\/ajpregu.00357.2011","article-title":"Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic rat","volume":"302","author":"Thomson","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119938_bib81","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1681\/ASN.2007060721","article-title":"Lack of A1 adenosine receptors augments diabetic hyperfiltration and glomerular injury","volume":"19","author":"Faulhaber-Walter","year":"2008","journal-title":"J. Am. Soc. Nephrol. JASN"},{"issue":"3","key":"10.1016\/j.biopha.2026.119938_bib82","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1748-1716.2007.01705.x","article-title":"Diabetes-induced hyperfiltration in adenosine A(1)-receptor deficient mice lacking the tubuloglomerular feedback mechanism","volume":"190","author":"S\u00e4llstr\u00f6m","year":"2007","journal-title":"Acta Physiol. (Oxf. Engl. )"},{"issue":"2","key":"10.1016\/j.biopha.2026.119938_bib83","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1681\/ASN.2014030278","article-title":"A potential role for mechanical forces in the detachment of podocytes and the progression of CKD","volume":"26","author":"Kriz","year":"2015","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"10.1016\/j.biopha.2026.119938_bib84","doi-asserted-by":"crossref","unstructured":"Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Journal of the American Society of Nephrology: JASN 2001, 12(6):1315-1325.","DOI":"10.1681\/ASN.V1261315"},{"issue":"4","key":"10.1016\/j.biopha.2026.119938_bib85","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1159\/000081555","article-title":"Viable podocytes detach in experimental diabetic nephropathy: potential mechanism underlying glomerulosclerosis","volume":"98","author":"Petermann","year":"2004","journal-title":"Nephron Exp. Nephrol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119938_bib86","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1172\/JCI111523","article-title":"Structural-functional relationships in diabetic nephropathy","volume":"74","author":"Mauer","year":"1984","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.biopha.2026.119938_bib87","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.2010010010","article-title":"Pathologic classification of diabetic nephropathy","volume":"21","author":"Tervaert","year":"2010","journal-title":"J. Am. Soc. Nephrol. JASN"},{"issue":"10","key":"10.1016\/j.biopha.2026.119938_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11100578","article-title":"Endothelial Toxicity of High Glucose and its by-Products in Diabetic Kidney Disease","volume":"11","author":"Dou","year":"2019","journal-title":"Toxins"},{"issue":"2","key":"10.1016\/j.biopha.2026.119938_bib89","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41581-018-0098-z","article-title":"Endothelium structure and function in kidney health and disease","volume":"15","author":"Jourde-Chiche","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"issue":"24","key":"10.1016\/j.biopha.2026.119938_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249456","article-title":"Molecular Mechanisms in Early Diabetic Kidney Disease: Glomerular Endothelial Cell Dysfunction","volume":"21","author":"Lass\u00e9n","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"7327","key":"10.1016\/j.biopha.2026.119938_bib91","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/nature09599","article-title":"S-glutathionylation uncouples eNOS and regulates its cellular and vascular function","volume":"468","author":"Chen","year":"2010","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.biopha.2026.119938_bib92","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/CIRCULATIONAHA.105.602532","article-title":"Endothelial nitric oxide synthase in vascular disease: from marvel to menace","volume":"113","author":"F\u00f6rstermann","year":"2006","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.biopha.2026.119938_bib93","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1006\/bbrc.1999.1422","article-title":"Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function","volume":"263","author":"Milstien","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2026.119938_bib94","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1074\/jbc.M805403200","article-title":"Quantitative regulation of intracellular endothelial nitric-oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status: insights from cells with tet-regulated GTP cyclohydrolase I expression","volume":"284","author":"Crabtree","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.biopha.2026.119938_bib95","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1089\/ars.2011.3904","article-title":"S-glutathionylation reshapes our understanding of endothelial nitric oxide synthase uncoupling and nitric oxide\/reactive oxygen species-mediated signaling","volume":"14","author":"Zweier","year":"2011","journal-title":"Antioxid. & Redox Signal."},{"issue":"11","key":"10.1016\/j.biopha.2026.119938_bib96","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.2337\/db11-0901","article-title":"Arginase-2 mediates diabetic renal injury","volume":"60","author":"Morris","year":"2011","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.biopha.2026.119938_bib97","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/ki.2013.215","article-title":"Arginase inhibition mediates renal tissue protection in diabetic nephropathy by a nitric oxide synthase 3-dependent mechanism","volume":"84","author":"You","year":"2013","journal-title":"Kidney Int."},{"issue":"19","key":"10.1016\/j.biopha.2026.119938_bib98","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142187","article-title":"Selective inhibition of arginase-2 in endothelial cells but not proximal tubules reduces renal fibrosis","volume":"5","author":"Wetzel","year":"2020","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.biopha.2026.119938_bib99","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1172\/JCI11235","article-title":"Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site","volume":"108","author":"Du","year":"2001","journal-title":"J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.biopha.2026.119938_bib100","doi-asserted-by":"crossref","first-page":"E68","DOI":"10.1161\/hh1101.092677","article-title":"Phosphorylation of Thr(495) regulates Ca(2+)\/calmodulin-dependent endothelial nitric oxide synthase activity","volume":"88","author":"Fleming","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2026.119938_bib101","article-title":"Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes","volume":"2012","author":"Funk","year":"2012","journal-title":"Int. J. Vasc. Med."},{"issue":"10","key":"10.1016\/j.biopha.2026.119938_bib102","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.RES.87.10.840","article-title":"Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress","volume":"87","author":"Cai","year":"2000","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119938_bib103","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1172\/JCI118074","article-title":"Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines","volume":"96","author":"De Caterina","year":"1995","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.biopha.2026.119938_bib104","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1742-7843.2011.00785.x","article-title":"Reactive oxygen species and endothelial function--role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases","volume":"110","author":"Montezano","year":"2012","journal-title":"Basic. & Clin. Pharmacol. & Toxicol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119938_bib105","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.2337\/db13-0795","article-title":"Endothelial-podocyte crosstalk: the missing link between endothelial dysfunction and albuminuria in diabetes","volume":"62","author":"Siddiqi","year":"2013","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.biopha.2026.119938_bib106","doi-asserted-by":"crossref","first-page":"F287","DOI":"10.1152\/ajprenal.00533.2014","article-title":"Glomerular endothelial cell injury and cross talk in diabetic kidney disease","volume":"308","author":"Fu","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119938_bib107","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/path.3964","article-title":"Endothelial glycocalyx dysfunction in disease: albuminuria and increased microvascular permeability","volume":"226","author":"Salmon","year":"2012","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119938_bib108","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1681\/ASN.2006050459","article-title":"Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy","volume":"18","author":"Nakagawa","year":"2007","journal-title":"J. Am. Soc. Nephrol. JASN"},{"issue":"10","key":"10.1016\/j.biopha.2026.119938_bib109","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1681\/ASN.2006070798","article-title":"Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice","volume":"17","author":"Zhao","year":"2006","journal-title":"J. Am. Soc. Nephrol. JASN"},{"issue":"3","key":"10.1016\/j.biopha.2026.119938_bib110","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00424-007-0212-8","article-title":"The endothelial glycocalyx: composition, functions, and visualization","volume":"454","author":"Reitsma","year":"2007","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119938_bib111","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1161\/ATVBAHA.118.310839","article-title":"Endothelial Glycocalyx as a Shield Against Diabetic Vascular Complications: Involvement of Hyaluronan and Hyaluronidases","volume":"38","author":"Dogn\u00e9","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119938_bib112","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1681\/ASN.2012010017","article-title":"Loss of the endothelial glycocalyx links albuminuria and vascular dysfunction","volume":"23","author":"Salmon","year":"2012","journal-title":"J. Am. Soc. Nephrol. JASN"},{"issue":"12","key":"10.1016\/j.biopha.2026.119938_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167576","article-title":"Glycocalyx Degradation Induces a Proinflammatory Phenotype and Increased Leukocyte Adhesion in Cultured Endothelial Cells under Flow","volume":"11","author":"McDonald","year":"2016","journal-title":"PloS. One"},{"issue":"11","key":"10.1016\/j.biopha.2026.119938_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2025.101122","article-title":"The Endothelial Glycocalyx: The First Line of Defense in the Prevention and Treatment of Kidney Diseases","volume":"7","author":"Yuan","year":"2025","journal-title":"Kidney Med."},{"issue":"4","key":"10.1016\/j.biopha.2026.119938_bib115","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2337\/diabetes.55.04.06.db05-1619","article-title":"Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes","volume":"55","author":"Nieuwdorp","year":"2006","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.biopha.2026.119938_bib116","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2337\/diabetes.55.02.06.db05-1103","article-title":"Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo","volume":"55","author":"Nieuwdorp","year":"2006","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.biopha.2026.119938_bib117","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrneph.2015.162","article-title":"The glycocalyx--linking albuminuria with renal and cardiovascular disease","volume":"11","author":"Rabelink","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"issue":"18","key":"10.1016\/j.biopha.2026.119938_bib118","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14577","article-title":"Simulations of Glomerular Shear and Hoop Stresses in Diabetes, Hypertension, and Reduced Renal Mass using a Network Model of a Rat Glomerulus","volume":"8","author":"Richfield","year":"2020","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.biopha.2026.119938_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2024.1410764","article-title":"Modeling the interaction between tubuloglomerular feedback and myogenic mechanisms in the control of glomerular mechanics","volume":"15","author":"Richfield","year":"2024","journal-title":"Front. Physiol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119938_bib120","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s00125-008-1051-7","article-title":"The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007","volume":"51","author":"Fioretto","year":"2008","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.biopha.2026.119938_bib121","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1038\/s41440-024-01916-z","article-title":"Heterogeneous afferent arteriolopathy: a key concept for understanding blood pressure-dependent renal damage","volume":"47","author":"Kohagura","year":"2024","journal-title":"Hypertens. Res. Off. J. Jpn. Soc. Hypertens."},{"issue":"3","key":"10.1016\/j.biopha.2026.119938_bib122","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.kint.2024.05.006","article-title":"Evaluation of glomerular hemodynamic changes by sodium-glucose-transporter 2 inhibition in type 2 diabetic rats using in vivo imaging","volume":"106","author":"Wada","year":"2024","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.biopha.2026.119938_bib123","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCULATIONAHA.118.037418","article-title":"Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging","volume":"140","author":"Kidokoro","year":"2019","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.biopha.2026.119938_bib124","doi-asserted-by":"crossref","first-page":"771","DOI":"10.34067\/KID.0000000000000425","article-title":"SGLT2 Inhibitors and Kidney Protection: Mechanisms Beyond Tubuloglomerular Feedback","volume":"5","author":"Upadhyay","year":"2024","journal-title":"Kidney360"},{"issue":"6","key":"10.1016\/j.biopha.2026.119938_bib125","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s40620-017-0423-9","article-title":"A more tubulocentric view of diabetic kidney disease","volume":"30","author":"Zeni","year":"2017","journal-title":"J. Nephrol."},{"issue":"15","key":"10.1016\/j.biopha.2026.119938_bib126","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in Patients with Chronic Kidney Disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"New. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.biopha.2026.119938_bib127","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.193","article-title":"Carbon monoxide prevents TNF-\u03b1-induced eNOS downregulation by inhibiting NF-\u03baB-responsive miR-155-5p biogenesis","volume":"49","author":"Choi","year":"2017","journal-title":"Exp. & Mol. Med."},{"issue":"11","key":"10.1016\/j.biopha.2026.119938_bib128","first-page":"149","article-title":"Actions of angiotensin II on the renal microvasculature","volume":"10","author":"Arendshorst","year":"1999","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"10.1016\/j.biopha.2026.119938_bib129","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/947506","article-title":"Heterogeneous downregulation of angiotensin II AT1-A and AT1-B receptors in arterioles in STZ-induced diabetic rat kidneys","volume":"2014","author":"Razga","year":"2014","journal-title":"BioMed. Res. Int."},{"issue":"3","key":"10.1016\/j.biopha.2026.119938_bib130","first-page":"779","article-title":"Endothelin type A and B receptors in the control of afferent and efferent arterioles in mice","volume":"26","author":"Schildroth","year":"2011","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transplant. Assoc. - Eur. Ren. Assoc."},{"issue":"10","key":"10.1016\/j.biopha.2026.119938_bib131","first-page":"1966","article-title":"Ito S: The mechanisms underlying altered vascular resistance of glomerular afferent and efferent arterioles in diabetic nephropathy","volume":"18","author":"Arima","year":"2003","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transplant. Assoc. - Eur. Ren. Assoc."},{"issue":"5","key":"10.1016\/j.biopha.2026.119938_bib132","doi-asserted-by":"crossref","first-page":"460","DOI":"10.4239\/wjd.v14.i5.460","article-title":"Early diabetic kidney disease: focus on the glycocalyx","volume":"14","author":"Yu","year":"2023","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.biopha.2026.119938_bib133","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.659013","article-title":"Glomerular endothelial cell crosstalk with podocytes in diabetic kidney disease","volume":"8","author":"Mahtal","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.biopha.2026.119938_bib134","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1146\/annurev.physiol.65.050102.085738","article-title":"Paracrine factors in tubuloglomerular feedback: adenosine, ATP, and nitric oxide","volume":"65","author":"Schnermann","year":"2003","journal-title":"Annu. Rev. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119938_bib135","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/HYPERTENSIONAHA.114.04975","article-title":"Renal transporter activation during angiotensin-II hypertension is blunted in interferon-\u03b3-\/- and interleukin-17A-\/- mice","volume":"65","author":"Kamat","year":"2015","journal-title":"Hypertens. (Dallas Tex 1979)"},{"issue":"1","key":"10.1016\/j.biopha.2026.119938_bib136","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/HYPERTENSIONAHA.116.07493","article-title":"Interleukin-17A Regulates Renal Sodium Transporters and Renal Injury in Angiotensin II-Induced Hypertension","volume":"68","author":"Norlander","year":"2016","journal-title":"Hypertens. (Dallas Tex 1979)"},{"issue":"10","key":"10.1016\/j.biopha.2026.119938_bib137","doi-asserted-by":"crossref","first-page":"F1000","DOI":"10.1152\/ajprenal.00482.2015","article-title":"Macrophage-derived IL-6 contributes to ANG II-mediated angiotensinogen stimulation in renal proximal tubular cells","volume":"310","author":"O'Leary","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119938_bib138","doi-asserted-by":"crossref","first-page":"F283","DOI":"10.1152\/ajprenal.00047.2008","article-title":"Costimulation with angiotensin II and interleukin 6 augments angiotensinogen expression in cultured human renal proximal tubular cells","volume":"295","author":"Satou","year":"2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119938_bib139","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/1753944715585512","article-title":"Role of stimulated intrarenal angiotensinogen in hypertension","volume":"9","author":"Satou","year":"2015","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"issue":"2 Pt 2","key":"10.1016\/j.biopha.2026.119938_bib140","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/hy0202.103299","article-title":"Mechanism by which superoxide potentiates tubuloglomerular feedback","volume":"39","author":"Ren","year":"2002","journal-title":"Hypertens. (Dallas Tex 1979)"},{"issue":"1","key":"10.1016\/j.biopha.2026.119938_bib141","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1002\/j.2040-4603.2023.tb00248.x","article-title":"The Role of Macula Densa Nitric Oxide Synthase 1 Beta Splice Variant in Modulating Tubuloglomerular Feedback","volume":"13","author":"Liu","year":"2023","journal-title":"Compr. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119938_bib142","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12964-023-01323-w","article-title":"Cellular crosstalk of mesangial cells and tubular epithelial cells in diabetic kidney disease","volume":"21","author":"Jiang","year":"2023","journal-title":"Cell communication signaling CCS"},{"issue":"3","key":"10.1016\/j.biopha.2026.119938_bib143","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12763","article-title":"Crosstalk between tubular epithelial cells and glomerular endothelial cells in diabetic kidney disease","volume":"53","author":"Chen","year":"2020","journal-title":"Cell. Prolif."},{"issue":"6","key":"10.1016\/j.biopha.2026.119938_bib144","article-title":"Single-cell RNA-seq with spatial transcriptomics to create an atlas of human diabetic kidney disease","volume":"37","author":"Chen","year":"2023","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119938_bib145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27010279","article-title":"Multi-Omics Integration Identifies TNFRSF1A as a Causal Mediator of Immune Microenvironment Reprogramming in Diabetic Kidney Disease","volume":"27","author":"Xie","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119938_bib146","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneph.2017.31","article-title":"The role of the complement system in diabetic nephropathy","volume":"13","author":"Flyvbjerg","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119938_bib147","first-page":"2019","article-title":"Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation","volume":"150","author":"Kilgore","year":"1997","journal-title":"Am. J. Pathol."},{"issue":"15","key":"10.1016\/j.biopha.2026.119938_bib148","doi-asserted-by":"crossref","first-page":"9053","DOI":"10.1016\/S0021-9258(18)81901-9","article-title":"Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface","volume":"264","author":"Hattori","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2026.119938_bib149","first-page":"7540","article-title":"response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells","volume":"34","author":"Shivshankar","year":"2020","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.biopha.2026.119938_bib150","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1340156","article-title":"Bidirectional Crosstalk between C5a Receptors and the NLRP3 Inflammasome in Macrophages and Monocytes","volume":"2016","author":"Haggadone","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2026.119938_bib151","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1778759","article-title":"Complement and inflammasome crosstalk in chronic inflammation","volume":"17","author":"Jan\u017ei\u010d","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119938_bib152","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2026.1747053","article-title":"Molecular pathways and emerging therapeutic targets in the pathogenesis of diabetic kidney disease","volume":"17","author":"Al-Masri","year":"2026","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2026.119938_bib153","article-title":"Metabolic Crosstalk in Diabetic Kidney Disease: Synergistic Effects of Glucotoxicity and Lipotoxicity","volume":"19","author":"Cao","year":"2026","journal-title":"Diabetes metabolic syndrome obesity targets therapy"},{"key":"10.1016\/j.biopha.2026.119938_bib154","article-title":"Multi-omics analysis reveals the pathogenesis of db\/db mice diabetic kidney disease and the treatment mechanisms of multi-bioactive compounds combination from Salvia miltiorrhiza","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119938_bib155","article-title":"Diabetic kidney disease: integrating multi-omics insights, artificial intelligence, and novel therapeutics for precision medicine","volume":"17","author":"Li","year":"2026","journal-title":"Front. Genet."},{"key":"10.1016\/j.biopha.2026.119938_bib156","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1602594","article-title":"Immune inflammation and metabolic interactions in the pathogenesis of diabetic nephropathy","volume":"16","author":"Hou","year":"2025","journal-title":"Front. Endocrinol."},{"issue":"22","key":"10.1016\/j.biopha.2026.119938_bib157","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216543","article-title":"Endothelial Glycocalyx of Peritubular Capillaries in Experimental Diabetic Nephropathy: A Target of ACE Inhibitor-Induced Kidney Microvascular Protection","volume":"24","author":"Locatelli","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2026.119938_bib158","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1016\/j.ekir.2024.05.005","article-title":"The Role of Mitochondrial Dysfunction in CKD-Related Vascular Calcification: From Mechanisms to Therapeutics","volume":"9","author":"Huang","year":"2024","journal-title":"Kidney Int. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2026.119938_bib159","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10060218","article-title":"The Impact of Uremic Toxins on Vascular Smooth Muscle Cell Function","volume":"10","author":"H\u00e9naut","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.biopha.2026.119938_bib160","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2147\/DMSO.S513080","article-title":"Diabetic kidney disease: disease progression driven by positive feedback loops and therapeutic strategies targeting pathogenic pathways","volume":"18","author":"Mo","year":"2025","journal-title":"Diabetes metabolic syndrome obesity targets therapy"},{"key":"10.1016\/j.biopha.2026.119938_bib161","article-title":"Unveiling the pathogenesis and therapeutic approaches for diabetic nephropathy: insights from panvascular diseases","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2026.119938_bib162","article-title":"Comparison of Nonalbuminuric and Albuminuric Diabetic Kidney Disease Among Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis","volume":"13","author":"Shi","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119938_bib163","doi-asserted-by":"crossref","DOI":"10.3390\/biom13050752","article-title":"Update on diabetic kidney disease (DKD): focus on non-albuminuric DKD and Cardiovascular Risk","volume":"13","author":"Scilletta","year":"2023","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.biopha.2026.119938_bib164","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1007\/s00125-005-0002-9","article-title":"Renal hyperfiltration in type 2 diabetes: effect of age-related decline in glomerular filtration rate","volume":"48","author":"Premaratne","year":"2005","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.biopha.2026.119938_bib165","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.ekir.2023.11.030","article-title":"Longitudinal Trajectories of Biomarkers of Kidney Tubular Function in Type 1 Diabetes","volume":"9","author":"Limonte","year":"2024","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.biopha.2026.119938_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.111017","article-title":"Circulating tumor necrosis factor-related biomarkers predict kidney function decline in Japanese patients with diabetes: an observational cohort study","volume":"206","author":"Murakoshi","year":"2023","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"4","key":"10.1016\/j.biopha.2026.119938_bib167","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ki.2014.330","article-title":"Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes","volume":"87","author":"Pavkov","year":"2015","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.biopha.2026.119938_bib168","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3556","article-title":"Review of potential biomarkers of inflammation and kidney injury in diabetic kidney disease","volume":"38","author":"Khanijou","year":"2022","journal-title":"Diabetes\/Metab. Res. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2026.119938_bib169","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41591-019-0415-5","article-title":"A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes","volume":"25","author":"Niewczas","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2026.119938_bib170","first-page":"1","article-title":"Circulating proteins for prediction of kidney disease progression and cardiovascular outcomes: individual participant data meta-analysis of four cohorts","author":"Lopez-Silva","year":"2025","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.biopha.2026.119938_bib171","article-title":"Emerging technologies for early risk stratification and precision management of diabetic kidney disease: a multimodal framework integrating digital phenotypes and clinical biomarkers","volume":"16","author":"Meng","year":"2025","journal-title":"Front. Endocrinol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119938_bib172","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"New. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.biopha.2026.119938_bib173","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"New. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.biopha.2026.119938_bib174","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"New. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.biopha.2026.119938_bib175","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in Patients with Chronic Kidney Disease","volume":"388","author":"Herrington","year":"2023","journal-title":"New. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119938_bib176","article-title":"SGLT2 inhibitor counteracts NLRP3 inflammasome via tubular metabolite itaconate in fibrosis kidney","volume":"36","author":"Ke","year":"2022","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119938_bib177","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","article-title":"Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Eur. Heart J."},{"issue":"24","key":"10.1016\/j.biopha.2026.119938_bib178","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"New. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.biopha.2026.119938_bib179","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/eurheartj\/ehae613","article-title":"Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial","volume":"46","author":"Mahaffey","year":"2025","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2026.119938_bib180","doi-asserted-by":"crossref","DOI":"10.1177\/20420188231222367","article-title":"Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications","volume":"15","author":"Alharbi","year":"2024","journal-title":"Ther. Adv. Endocrinol. Metab."},{"issue":"16","key":"10.1016\/j.biopha.2026.119938_bib181","doi-asserted-by":"crossref","DOI":"10.3390\/cells11162587","article-title":"Induced Human Regulatory T Cells Express the Glucagon-like Peptide-1 Receptor","volume":"11","author":"Rode","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.biopha.2026.119938_bib182","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/dom.15410","article-title":"Effect of tirzepatide on albuminuria levels and renal function in patients with type 2 diabetes mellitus: A systematic review and multilevel meta-analysis","volume":"26","author":"Karakasis","year":"2024","journal-title":"Diabetes Obes. & Metab."},{"issue":"3","key":"10.1016\/j.biopha.2026.119938_bib183","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2337\/dc24-1773","article-title":"Tirzepatide Associated With Reduced Albuminuria in Participants With Type 2 Diabetes: Pooled Post Hoc Analysis From the Randomized Active- and Placebo-Controlled SURPASS-1-5 Clinical Trials","volume":"48","author":"Apperloo","year":"2025","journal-title":"Diabetes care"},{"key":"10.1016\/j.biopha.2026.119938_bib184","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnag022","article-title":"Newer and novel antidiabetic drug classes across the cardiovascular\u2013kidney\u2013metabolic continuum","author":"Stefanakis","year":"2026","journal-title":"Endocr. Rev."},{"issue":"8","key":"10.1016\/j.biopha.2026.119938_bib185","first-page":"1559","article-title":"COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics","volume":"40","author":"Agarwal","year":"2025","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transplant. Assoc. - Eur. Ren. Assoc."},{"key":"10.1016\/j.biopha.2026.119938_bib186","doi-asserted-by":"crossref","unstructured":"Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2026. Diabetes care 2026, 49(Suppl 1):S246-s260.","DOI":"10.2337\/dc26-S011"},{"issue":"1","key":"10.1016\/j.biopha.2026.119938_bib187","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1681\/ASN.2014010012","article-title":"Effect of pentoxifylline on renal function and urinary albumin excretion in patients with diabetic kidney disease: the PREDIAN trial","volume":"26","author":"Navarro-Gonz\u00e1lez","year":"2015","journal-title":"J. Am. Soc. Nephrol. JASN"},{"issue":"10184","key":"10.1016\/j.biopha.2026.119938_bib188","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0140-6736(19)30772-X","article-title":"Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial","volume":"393","author":"Heerspink","year":"2019","journal-title":"Lancet (Lond. Engl. )"},{"issue":"11","key":"10.1016\/j.biopha.2026.119938_bib189","first-page":"1950","article-title":"JAK1\/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial","volume":"33","author":"Tuttle","year":"2018","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transplant. Assoc. - Eur. Ren. Assoc."},{"key":"10.1016\/j.biopha.2026.119938_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173503","article-title":"Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: Preclinical evidences with therapeutic approaches","volume":"885","author":"Ram","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"26","key":"10.1016\/j.biopha.2026.119938_bib191","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease","volume":"369","author":"de Zeeuw","year":"2013","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119938_bib192","first-page":"507","article-title":"Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes","volume":"23","author":"Niewczas","year":"2012"},{"issue":"6","key":"10.1016\/j.biopha.2026.119938_bib193","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1053\/j.ajkd.2021.09.018","article-title":"Associations of Plasma Biomarkers of Inflammation, Fibrosis, and Kidney Tubular Injury With Progression of Diabetic Kidney Disease: A Cohort Study","volume":"79","author":"Guti\u00e9rrez","year":"2022","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"issue":"6","key":"10.1016\/j.biopha.2026.119938_bib194","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00592-013-0485-7","article-title":"\"Normoalbuminuric\" diabetic nephropathy: tubular damage and NGAL","volume":"50","author":"Lacquaniti","year":"2013","journal-title":"Acta Diabetol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119938_bib195","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12882-018-1043-x","article-title":"Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease","volume":"19","author":"Satirapoj","year":"2018","journal-title":"BMC Nephrol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119938_bib196","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2562996","article-title":"Performance of novel biomarkers for prediction of diabetic kidney disease in patients with diabetes mellitus","volume":"57","author":"Zou","year":"2025","journal-title":"Ann. Med."},{"issue":"4","key":"10.1016\/j.biopha.2026.119938_bib197","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-8587(20)30026-7","article-title":"Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial","volume":"8","author":"Tofte","year":"2020","journal-title":"Lancet Diabetes & Endocrinol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T11:54:22Z","timestamp":1794743662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226009741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":197,"alternative-id":["S0753332226009741"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119938","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting immune\u2013hemodynamic coupling in early diabetic kidney disease: Mechanisms, biomarkers, and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119938","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119938"}}